Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
Abstract Survival in multiple myeloma (MM) has developed favorably over the past decades for reasons that have been ascribed to new medications and treatment. However, development of survival over a long period and comparison to other hematopoietic neoplasms (HN) is less well known. Here we used Swe...
Main Authors: | Kari Hemminki, Asta Försti, Markus Hansson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96804-8 |
Similar Items
-
Incidence and survival in non-hereditary amyloidosis in Sweden
by: Hemminki Kari, et al.
Published: (2012-11-01) -
Survival in colon and rectal cancers in Finland and Sweden through 50 years
by: Akseli Hemminki, et al.
Published: (2021-08-01) -
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma
by: Hemminki Kari, et al.
Published: (2012-10-01) -
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
by: Kari Hemminki, et al.
Published: (2021-01-01) -
Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
by: Kari Hemminki, et al.
Published: (2021-05-01)